Check it! Hehehe
$Eton Pharmaceutical(ETON.US$ Thu, 14 March 2024 at 5:35 PM GMT-4
• Revenue Growth: Q4 product sales and royalty revenue surged by 109% year-over-year to $7.3 million.
• Positive Cash Flow: ETON generated $0.4 million in operating cash flow in Q4, with a cash reserve of $21.4 million.
• Research and Development: R&D expenses slightly increased to $1.0 million in Q4, supporting progress in the company's drug pipeline.
• Net Loss: ETON reported a net loss of $2.3 million in Q4, attributed to a one-time payment and absence of prior year's licensing revenue.
• Revenue Growth: Q4 product sales and royalty revenue surged by 109% year-over-year to $7.3 million.
• Positive Cash Flow: ETON generated $0.4 million in operating cash flow in Q4, with a cash reserve of $21.4 million.
• Research and Development: R&D expenses slightly increased to $1.0 million in Q4, supporting progress in the company's drug pipeline.
• Net Loss: ETON reported a net loss of $2.3 million in Q4, attributed to a one-time payment and absence of prior year's licensing revenue.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
